Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3216 Magnesium Oxaloacetate Inhibitor of the amebicidal activity of activated murine macrophages, helping the parasite to survive within the mouse large intestine and increasing the survival of C. elegans exposed to H2O2
DCC3217 Magreth-16a Potent CB2 receptor inverse agonist
DCC3218 Malonganenone A Selective modulator of plasmodial Hsp70s with antimalarial activity
DCC3219 Malp-2 Featured Toll-like receptor 2/6 (TLR-2/6) agonist, regulating Lcn2 gene, promoting collateral growth
DCC3220 Malp-2s TLR2/6 agonist, activating the MyD88 pathway, provoking natural killer (NK) cell activation, increasing co-stimulators CD80/86 and CD40
DCC3221 Mal-rp Novel quantitative chemical probe for live cell labeling and imaging of proteins that are sensitive to redox modifications
DCC3222 Manassantin A Natural anticancer, anti-inflammatory, neuroleptic agent, also having human acyl-CoA:cholesterol acyltransferase (ACAT) inhibitory activities
DCC3223 Mao-b Inhibitor 58 Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B).
DCC3224 Mao-b Inhibitor C3 Novel potent and highly selective MAO-B Inhibitor
DCC3225 Mao-b Inhibitor C5 Potent and selective MAO-B inhibitor
DCC3226 Mao-b Inhibitor Cc1 Novel potent selective and competitive inhibitor of MAO-B (IC 50 : 0.69 μM)
DCC3227 Mao-b Inhibitor Cc2 Novel potent and competitive inhibitor of MAO-B (IC 50 : 0.51 μM), also inhibiting BChE (IC 50 : 7.00 μM)
DCC3228 Mao-b Ligand-1 Novel selective MAO-B inhibitor
DCC3229 Ma-pabc-adc-linker-18 Novel stable antibody-drug conjugate (ADC) in mouse serum
DCC3230 Maprotiline Inhibitor of neuronal norepinephrine reuptake, reducing symptoms of anxiety associated with depression.
DCC3231 Marbotinib Novel highly efficient dual type I/II FMS-like tyrosine kinase inhibitor, disrupting the growth of leukemic cells
DCC3232 Margatoxin Inhibitor of voltage-gated K(+) (Kv) channels Kv1.3 and Kv1.5
DCC3233 Maritinone Novel, active, and less toxic anti-tuberculosis (anti-TB) agent
DCC3234 Maropitant Citrate [359875-09-5] Featured Neurokinin receptor antagonist with antiemetic activity
DCC3235 Massiliamide Novel potent tyrosinase inhibitor from the Gram-negative bacterium Massilia albidiflava DSM 17472T
DCC3236 May1-in-13a Novel potent inhibitor of May1 with Ki = 12 ± 1 nM, also inhibiting wild-type HIV-1 protease with Ki = 32 ± 5 pM and three drug resistance-associated mutants with Ki values ranging from 24 to 320 pM
DCC3237 Maysin Natural Anti-inflammation Agent, Attenuating Amyloid Plaques by Inducing Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model
DCC3238 Mb-001 Novel potent inhibitor of the membrane-bound retinoid isomerase RPE65
DCC3239 Mb06322 Prodrug of MB05032, acting as potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes
DCC3240 Mb16695 Novel Inhibitor of Mycobacterium tuberculosis α-1,4-Glucan Branching Enzyme (GlgB)
DCC3241 Mb-211 Novel inhibitor of dengue and West Nile virus NS2B-NS3 protease
DCC3242 Mbls-in-5 Novel non-hemolytic and low toxic inhibitor of metallo-β-lactamases (MBLs), restoring the activity of meropenem against Escherichia coli, Citrobacter freundii, Proteus mirabilis and Klebsiella pneumonia, which carried resistance genes of blaNDM-1
DCC3243 Mbp-c12 Novel detergent, showing enhanced stability to all tested proteins compared to a gold standard detergent (DDM)
DCC3244 Mbp-c9 Novel detergent, showing enhanced stability to all tested proteins compared to a gold standard detergent (DDM)
DCC3245 Mbri-001 Deuterium-substituted anticancer agent, plinabulin, exhibiting better pharmacokinetic characteristics than that of plinabulin

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X